83 FR 26069 - National Cancer Institute; Notice of Meeting
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 83, Issue 108 (June 5, 2018)
National Institutes of Health
Federal Register Volume 83, Issue 108 (June 5, 2018)
| Page Range | 26069-26070 | |
| FR Document | 2018-11958 |
[Federal Register Volume 83, Number 108 (Tuesday, June 5, 2018)] [Notices] [Pages 26069-26070] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-11958] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the joint meeting of the National Cancer Advisory Board (NCAB) and NCI Board of Scientific Advisors (BSA). The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The open session will be videocast and can be accessed from the NIH Videocasting and Podcasting website (http://videocast.nih.gov). A portion of the National Cancer Advisory Board meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Advisory Board; Ad Hoc Subcommittee on Population Science, Epidemiology and Disparities. Open: June 25, 2018, 5:30 p.m. to 7:00 p.m. Agenda: Discussion on Population Science, Epidemiology and Disparities. Place: Gaithersburg Marriott Washingtonian Center, Room--To Be Determined, 9751 Washington Boulevard, Gaithersburg, MD 20878. Contact Person: Dr. Deborah Winn, Executive Secretary, NCAB Ad Hoc Subcommittee on Population Science, Epidemiology and Disparities, National Cancer Institute--Shady Grove, National Institutes of Health, 9609 Medical Center Drive, Room 4E344, Bethesda, MD 20892, (240) 276-6755, [email protected]. Name of Committee: National Cancer Advisory Board; Ad Hoc Subcommittee on Global Cancer Research. Open: June 25, 2018, 7:30 p.m. to 9:00 p.m. Agenda: Discussion on Global Cancer Research. Place: Gaithersburg Marriott Washingtonian Center, Room--To Be Determined, 9751 Washington Boulevard, Gaithersburg, MD 20878. Contact Person: Dr. Edward Trimble, Executive Secretary, NCAB Ad Hoc Subcommittee on Global Cancer Research, National Cancer Institute--Shady Grove, National Institutes of Health, 9609 Medical Center Drive, Room 3W562, Bethesda, MD 20892, (240) 276-5796, [email protected]. Name of Committee: National Cancer Advisory Board and NCI Board of Scientific Advisors. Open: June 26, 2018, 8:30 a.m. to 5:00 p.m. Agenda: Joint meeting of the National Cancer Advisory Board and NCI Board of Scientific Advisors, NCI Director's report and presentations, NCI Board of Scientific Advisors Concepts Review. Closed: June 26, 2018, 5:00 p.m. to 6:00 p.m. Agenda: Review of NCAB grant applications. Place: National Cancer Institute--Shady Grove 9609, Medical Center Drive, Room TE406 & 408 Rockville, MD 20850. Contact Person: Paulette S. Gray, Ph.D., Director, Division of Extramural Activities, National Cancer Institute--Shady Grove, National Institutes of Health, 9609 Medical Center Drive, Room 7W444, Bethesda, MD 20892, 240-276-6340, [email protected]. Name of Committee: National Cancer Advisory Board and NCI Board of Scientific Advisors. Open: June 27, 2018, 9:00 a.m. to 12:00 p.m. Agenda: Joint meeting of the National Cancer Advisory Board and NCI Board of Scientific Advisors, NCI Board of Scientific Advisors Concepts Review. Place: National Cancer Institute--Shady Grove 9609 Medical Center Drive, Room TE406 & 408 Rockville, MD 20850. Contact Person: Paulette S. Gray, Ph.D., Director, Division of Extramural Activities, National Cancer Institute--Shady Grove, National Institutes of Health, 9609 Medical Center Drive, Room 7W444, Bethesda, MD 20892, [email protected]. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on [[Page 26070]] this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NCI-Shady Grove campus. All visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and to state the purpose of their visit. Information is also available on the Institute's/Center's home page: NCAB: http://deainfo.nci.nih.gov/advisory/ncab/ncab.htm, BSA: http://deainfo.nci.nih.gov/advisory/bsa/bsa.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: May 30, 2018. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018-11958 Filed 6-4-18; 8:45 am] BILLING CODE 4140-01-P
![Federal Register / Vol. 83, No. 108 / Tuesday, June 5, 2018 / Notices 26069
Time: June 22, 2017, 8:00 a.m. to 3:00 p.m. Contact Person: Lilia Topol, Ph.D., Agenda: Discussion on Population Science,
Agenda: Evaluate sleep and circadian Scientific Review Officer, Center for Epidemiology and Disparities.
research activities; discuss plans for the Scientific Review, National Institutes of Place: Gaithersburg Marriott
proposed revision of the NIH Sleep Disorders Health, 6701 Rockledge Drive, Room 6192, Washingtonian Center, Room—To Be
Research Plan, and potential opportunities MSC 7804, Bethesda, MD 20892, 301–451– Determined, 9751 Washington Boulevard,
for the inter-agency coordination activities. 0131, ltopol@mail.nih.gov. Gaithersburg, MD 20878.
Place: National Institutes of Health, Two This notice is being published less than 15 Contact Person: Dr. Deborah Winn,
Rockledge Center, Conference Room 9100– days prior to the meeting due to the timing Executive Secretary, NCAB Ad Hoc
9104, 6701 Rockledge Drive, Bethesda, MD limitations imposed by the review and Subcommittee on Population Science,
20892. funding cycle. Epidemiology and Disparities, National
Contact Person: Michael J. Twery, Ph.D., (Catalogue of Federal Domestic Assistance Cancer Institute—Shady Grove, National
Director, National Center on Sleep Disorders Institutes of Health, 9609 Medical Center
Program Nos. 93.306, Comparative Medicine;
Research, Division of Lung Diseases, National Drive, Room 4E344, Bethesda, MD 20892,
93.333, Clinical Research, 93.306, 93.333,
Heart, Lung, and Blood Institute, National (240) 276–6755, winnde@mail.nih.gov.
93.337, 93.393–93.396, 93.837–93.844,
Institutes of Health, 6701 Rockledge Drive, Name of Committee: National Cancer
93.846–93.878, 93.892, 93.893, National
Suite 10170, Bethesda, MD 20892–7952, 301– Advisory Board; Ad Hoc Subcommittee on
435–0199, twerym@nhlbi.nih.gov. Institutes of Health, HHS)
Global Cancer Research.
Information is also available on the Dated: May 30, 2018. Open: June 25, 2018, 7:30 p.m. to 9:00 p.m.
Institute’s/Center’s home page: https:// David D. Clary, Agenda: Discussion on Global Cancer
www.nhlbi.nih.gov/about/committees/sdrab/, Program Analyst, Office of Federal Advisory Research.
where an agenda and any additional Committee Policy. Place: Gaithersburg Marriott
information for the meeting will be posted Washingtonian Center, Room—To Be
[FR Doc. 2018–11956 Filed 6–4–18; 8:45 am]
when available. Determined, 9751 Washington Boulevard,
BILLING CODE 4140–01–P
(Catalogue of Federal Domestic Assistance Gaithersburg, MD 20878.
Program Nos. 93.233, National Center for Contact Person: Dr. Edward Trimble,
Sleep Disorders Research; 93.837, Heart and Executive Secretary, NCAB Ad Hoc
Vascular Diseases Research; 93.838, Lung DEPARTMENT OF HEALTH AND Subcommittee on Global Cancer Research,
Diseases Research; 93.839, Blood Diseases HUMAN SERVICES National Cancer Institute—Shady Grove,
and Resources Research, National Institutes National Institutes of Health, 9609 Medical
of Health, HHS) National Institutes of Health Center Drive, Room 3W562, Bethesda, MD
Dated: May 30, 2018. 20892, (240) 276–5796, trimblet@
National Cancer Institute; Notice of mail.nih.gov.
Michelle D. Trout,
Meeting Name of Committee: National Cancer
Program Analyst, Office of Federal Advisory
Committee Policy. Pursuant to section 10(d) of the Advisory Board and NCI Board of Scientific
Advisors.
[FR Doc. 2018–11959 Filed 6–4–18; 8:45 am] Federal Advisory Committee Act, as Open: June 26, 2018, 8:30 a.m. to 5:00 p.m.
BILLING CODE 4140–01–P amended, notice is hereby given of the Agenda: Joint meeting of the National
joint meeting of the National Cancer Cancer Advisory Board and NCI Board of
Advisory Board (NCAB) and NCI Board Scientific Advisors, NCI Director’s report and
DEPARTMENT OF HEALTH AND of Scientific Advisors (BSA). presentations, NCI Board of Scientific
HUMAN SERVICES The meeting will be open to the Advisors Concepts Review.
public as indicated below, with Closed: June 26, 2018, 5:00 p.m. to 6:00
National Institutes of Health attendance limited to space available. p.m.
Individuals who plan to attend and Agenda: Review of NCAB grant
Center For Scientific Review; Notice of applications.
Closed Meeting need special assistance, such as sign Place: National Cancer Institute—Shady
language interpretation or other Grove 9609, Medical Center Drive, Room
Pursuant to section 10(d) of the reasonable accommodations, should TE406 & 408 Rockville, MD 20850.
Federal Advisory Committee Act, as notify the Contact Person listed below Contact Person: Paulette S. Gray, Ph.D.,
amended, notice is hereby given of the in advance of the meeting. The open Director, Division of Extramural Activities,
following meeting. session will be videocast and can be National Cancer Institute—Shady Grove,
The meeting will be closed to the accessed from the NIH Videocasting and National Institutes of Health, 9609 Medical
public in accordance with the Podcasting website (http:// Center Drive, Room 7W444, Bethesda, MD
provisions set forth in sections videocast.nih.gov). 20892, 240–276–6340, grayp@mail.nih.gov.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., A portion of the National Cancer Name of Committee: National Cancer
as amended. The grant applications and Advisory Board and NCI Board of Scientific
Advisory Board meeting will be closed
the discussions could disclose Advisors.
to the public in accordance with the Open: June 27, 2018, 9:00 a.m. to 12:00
confidential trade secrets or commercial provisions set forth in sections p.m.
property such as patentable material, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Agenda: Joint meeting of the National
and personal information concerning as amended. The grant applications and Cancer Advisory Board and NCI Board of
individuals associated with the grant the discussions could disclose Scientific Advisors, NCI Board of Scientific
applications, the disclosure of which confidential trade secrets or commercial Advisors Concepts Review.
would constitute a clearly unwarranted property such as patentable material, Place: National Cancer Institute—Shady
invasion of personal privacy. and personal information concerning Grove 9609 Medical Center Drive, Room
TE406 & 408 Rockville, MD 20850.
Name of Committee: Center for Scientific individuals associated with the grant
Review Special Emphasis Panel; Small Contact Person: Paulette S. Gray, Ph.D.,
applications, the disclosure of which
amozie on DSK3GDR082PROD with NOTICES1
Business: Cancer Drug Development and Director, Division of Extramural Activities,
would constitute a clearly unwarranted National Cancer Institute—Shady Grove,
Therapeutics.
invasion of personal privacy. National Institutes of Health, 9609 Medical
Date: June 18–19, 2018.
Time: 8:00 a.m. to 5:00 p.m. Name of Committee: National Cancer Center Drive, Room 7W444, Bethesda, MD
Agenda: To review and evaluate grant Advisory Board; Ad Hoc Subcommittee on 20892, grayp@mail.nih.gov.
applications. Population Science, Epidemiology and Any interested person may file written
Place: Residence Inn Bethesda, 7335 Disparities. comments with the committee by forwarding
Wisconsin Avenue, Bethesda, MD 20814. Open: June 25, 2018, 5:30 p.m. to 7:00 p.m. the statement to the Contact Person listed on
VerDate Sep<11>2014 20:19 Jun 04, 2018 Jkt 241001 PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 E:\FR\FM\05JNN1.SGM 05JNN1](https://thefederalregister.org/doc/83_FR_26177/page/1.svg)
![26070 Federal Register / Vol. 83, No. 108 / Tuesday, June 5, 2018 / Notices
this notice. The statement should include the Boulevard, Rockville, MD 20852 (Telephone commercialization of results of
name, address, telephone number and when Conference Call). federally-funded research and
applicable, the business or professional Contact Person: Ernest W. Lyons, Ph.D., development. Foreign patent
affiliation of the interested person. Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
applications are filed on selected
In the interest of security, NIH has
instituted stringent procedures for entrance Center, 6001 Executive Blvd, Suite 3208, inventions to extend market coverage
onto the NCI-Shady Grove campus. All MSC 9529, Bethesda, MD 20892–9529, (301) for companies and may also be available
visitors will be asked to show one form of 496–4056, lyonse@ninds.nih.gov. for licensing. A description of the
identification (for example, a government- Name of Committee: National Institute of technology follows.
issued photo ID, driver’s license, or passport) Neurological Disorders and Stroke Special
and to state the purpose of their visit. Emphasis Panel; Research Education
Octopod (8-Pointed Star) Iron Oxide
Information is also available on the Programs for Residents and Fellows. Nanoparticles Enhance MRI T2
Institute’s/Center’s home page: NCAB: http:// Date: June 29, 2018. Contrast
deainfo.nci.nih.gov/advisory/ncab/ncab.htm, Time: 11:00 a.m. to 3:00 p.m. Description of Technology: The
BSA: http://deainfo.nci.nih.gov/advisory/ Agenda: To review and evaluate grant
applications.
octopod-shaped iron oxide
bsa/bsa.htm, where an agenda and any
additional information for the meeting will Place: National Institutes of Health, nanoparticles of this technology
be posted when available. Neuroscience Center, 6001 Executive significantly enhance contrast in MRI
(Catalogue of Federal Domestic Assistance Boulevard, Rockville, MD 20852 (Telephone imaging compared to spherical
Program Nos. 93.392, Cancer Construction; Conference Call). superparamagnetic iron oxide
93.393, Cancer Cause and Prevention Contact Person: Ernest W. Lyons, Ph.D., nanoparticle T2 contrast agents. These
Research; 93.394, Cancer Detection and Scientific Review Officer, Scientific Review octopod iron oxide nanoparticles show
Diagnosis Research; 93.395, Cancer Branch, NINDS/NIH/DHHS, Neuroscience a transverse relaxivity that is over five
Treatment Research; 93.396, Cancer Biology Center, 6001 Executive Blvd, Suite 3208,
MSC 9529, Bethesda, MD 20892–9529, (301)
times greater than comparable spherical
Research; 93.397, Cancer Centers Support; agents. Because the unique octopod
93.398, Cancer Research Manpower; 93.399, 496–4056, lyonse@ninds.nih.gov.
Cancer Control, National Institutes of Health, (Catalogue of Federal Domestic Assistance shape creates a greater effective radius
HHS) Program Nos. 93.853, Clinical Research than spherical agents, but maintains
Related to Neurological Disorders; 93.854, similar magnetization properties, the
Dated: May 30, 2018. relaxation rate is improved. The
Biological Basis Research in the
Melanie J. Pantoja, Neurosciences, National Institutes of Health, improved relaxation rate greatly
Program Analyst, Office of Federal Advisory HHS) enhances the contrast of images. These
Committee Policy. octopod agents appear to be bio-
Dated: May 30, 2018.
[FR Doc. 2018–11958 Filed 6–4–18; 8:45 am] compatible and may be suitable for
Sylvia L. Neal,
BILLING CODE 4140–01–P
Program Analyst, Office of Federal Advisory intravenous delivery. The synthesis of
Committee Policy. these agents is also easily reproducible
[FR Doc. 2018–11963 Filed 6–4–18; 8:45 am] and scaled. The superior contrast greatly
DEPARTMENT OF HEALTH AND improves diagnostic sensitivities,
BILLING CODE 4140–01–P
HUMAN SERVICES compared to current FDA approved
spherical contrast agents. These
National Institutes of Health octopod-shaped iron oxide nanoparticle
DEPARTMENT OF HEALTH AND
National Institute of Neurological HUMAN SERVICES T2 contrast agents may have a number
Disorders and Stroke; Notice of Closed of medical imaging uses, such as tumor
Meetings National Institutes of Health detection, atherosclerosis imaging and
delivery of therapeutic treatments.
Pursuant to section 10(d) of the Government-Owned Inventions; Potential Commercial Applications:
Federal Advisory Committee Act, as Availability for Licensing Medical imaging, such as tumor
amended, notice is hereby given of the AGENCY: National Institutes of Health, detection, atherosclerosis imaging and
following meetings. HHS. delivery of therapeutic treatments.
The meetings will be closed to the Competitive Advantages:
ACTION: Notice.
public in accordance with the —Enhanced T2 contrast
provisions set forth in sections SUMMARY: The inventions listed below —Reproducible and scalable synthesis
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., are owned by an agency of the U.S. —Improved imaging and diagnostic
as amended. The grant applications and Government and are available for capability
the discussions could disclose licensing in the U.S. Development Stage: In vivo data
confidential trade secrets or commercial FOR FURTHER INFORMATION CONTACT: available (animal).
property such as patentable material, Licensing information and copies of the Inventors: Xiaoyuan Chen (NIBIB),
and personal information concerning patent applications listed below may be Jinhao Gao (Xiamen University, China),
individuals associated with the grant obtained by emailing the indicated Zhenghuan Zhao (Xiamen University,
applications, the disclosure of which licensing contact at the National Heart, China).
would constitute a clearly unwarranted Lung, and Blood, Office of Technology Publication: Zhao Z, et al. Octapod
invasion of personal privacy. Transfer and Development, Office of iron oxide nanoparticles as high-
Name of Committee: National Institute of Technology Transfer, 31 Center Drive, performance T2 contrast agents for
Neurological Disorders and Stroke Special Room 4A29, MSC 2479, Bethesda, MD magnetic resonance imaging. Nat
amozie on DSK3GDR082PROD with NOTICES1
Emphasis Panel; Summer Research 20892–2479; telephone: 301–402–5579. Commun. 2013;4:2266. [PMID
Education Experience Programs. A signed Confidential Disclosure 23903002]
Date: June 19, 2018. Agreement may be required to receive
Time: 1:00 p.m. to 4:00 p.m.
Intellectual Property: HHS Reference
Agenda: To review and evaluate grant
copies of the patent applications. No. E–314–2013/0—PCT Application
applications. SUPPLEMENTARY INFORMATION: This No. PCT/CN2013/076645 filed June 3,
Place: National Institutes of Health, notice is in accordance with 35 U.S.C. 2013. Chinese Patent Application
Neuroscience Center, 6001 Executive 209 and 37 CFR part 404 to achieve 201380077163.3 filed December 3, 2015.
VerDate Sep<11>2014 20:19 Jun 04, 2018 Jkt 241001 PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 E:\FR\FM\05JNN1.SGM 05JNN1](https://thefederalregister.org/doc/83_FR_26177/page/2.svg)
Document Created: 2018-11-02 11:46:59
Document Modified: 2018-11-02 11:46:59
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| FR Citation | 83 FR 26069 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR